Cardiac cachexia is a complex and severe condition characterized by the unintended loss of weight, muscle atrophy, and weakness in individuals with chronic heart failure. This condition goes beyond mere weight loss, encompassing a profound depletion of lean body mass and fat stores. It poses a significant challenge in the management of heart failure, often leading to increased morbidity and mortality. The underlying mechanisms of cardiac cachexia involve a complex interplay of inflammation, hormonal imbalance, and metabolic disturbances. Clinically, patients with cardiac cachexia experience a decline in functional capacity and a compromised quality of life. Management strategies typically involve a multidisciplinary approach, focusing on nutritional support, exercise rehabilitation, and addressing the underlying causes of heart failure. Research into the pathophysiology and treatment options for cardiac cachexia is ongoing, aiming to enhance our understanding and improve the prognosis for individuals affected by this debilitating condition.
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Study of pathological cardiac hypertrophy regression
Shuping Zhong, University of Southern California, United States
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Atypical takotsubo cardiomyopathy presenting as st-elevation myocardial infarction
Sana Tariq, Manchester University NHS Foundation Trust, United Kingdom